Compare Ganges Securitie with Similar Stocks
Dashboard
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 1.01%
- Poor long term growth as Net Sales has grown by an annual rate of -0.33% and Operating profit at -25.70%
Negative results in Dec 25
With ROE of 0.2, it has a Very Expensive valuation with a 0.2 Price to Book Value
Below par performance in long term as well as near term
Total Returns (Price + Dividend) 
Ganges Securitie for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Ganges Securities Ltd is Rated Strong Sell
Ganges Securities Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 25 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 03 March 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Ganges Securities Ltd is Rated Strong Sell
Ganges Securities Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 25 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.
Read full news articleAre Ganges Securities Ltd latest results good or bad?
Ganges Securities Ltd's latest financial results present a mixed picture. In Q2 FY26, the company reported net sales of ₹15.51 crores, reflecting a substantial sequential growth of 143.87% from ₹6.36 crores in Q1 FY26, although year-on-year growth was modest at 2.31% compared to ₹15.16 crores in Q2 FY25. The net profit for the same quarter was ₹2.91 crores, which shows a significant sequential improvement of 182.52% from ₹1.03 crores in Q1 FY26, yet it marks a notable decline of 59.70% from ₹7.22 crores in Q2 FY25. The company's operating profit margin (excluding other income) improved to 31.91% in Q2 FY26 from 13.99% in the previous quarter, but it remains below the 58.97% margin achieved in the same quarter last year. The PAT margin also increased to 18.76% from 16.19% in Q1 FY26, but it is substantially lower than the 47.63% recorded in Q2 FY25. A critical concern is the return on equity (ROE), which s...
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
12-Feb-2026 | Source : BSENewspaper publication
Board Meeting Outcome for Outcome Of Board Meeting
11-Feb-2026 | Source : BSEPursuant to Regulation 30 and 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. February 11 2026 has inter-alia considered and approved the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter year ended December 31 2025. A copy of Unaudited Financial Results along with Auditors Limited Report thereon is enclosed for your records; The meeting commenced at 3:45 p.m. and concluded at 4.30 p.m. The above is for your information and dissemination to all concerned.
Financial Results For The Quarter Ended December 31 2025
11-Feb-2026 | Source : BSEFinancial Results for the quarter ended December 31 2025
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 1 Schemes (0.01%)
Held by 1 FIIs (0.03%)
Sil Investments Limited (13.38%)
Navjeewan Medical Institute (6.21%)
21.88%
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
YoY Growth in quarter ended Dec 2025 is -14.20% vs 1.00% in Dec 2024
YoY Growth in quarter ended Dec 2025 is 82.50% vs -40.30% in Dec 2024
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -4.41% vs 19.10% in Sep 2024
Growth in half year ended Sep 2025 is -52.87% vs 35.93% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -7.98% vs 11.81% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -41.05% vs 22.30% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 9.08% vs -15.57% in Mar 2024
YoY Growth in year ended Mar 2025 is 45.40% vs -64.31% in Mar 2024






